• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

News

Article

Daily Derm Times: February 24, 2025

Key Takeaways

  • Marketing anti-aging products to children raises ethical concerns due to potential harm and lack of necessity.
  • Roflumilast may fill a significant treatment gap for pediatric atopic dermatitis if approved.
SHOW MORE

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Daily Derm Times logo

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Ethical Considerations and Guidance of Cosmeceuticals in Pediatric Care

The promotion of anti-aging products to children, who don't yet experience age-related skin changes, is both ethically questionable and potentially harmful.

Phase 3 Trial Supports Roflumilast for Pediatric AD

Lead author on recent research, Lawrence Eichenfield, MD, said if approved, this treatment could fill a “significant gap.”

Sunscreen is the Best Way to Prevent Post-Inflammatory Hyperpigmentation in Skin of Color

Although more research is needed to fill this gap, sunscreen had the greatest success rates of all the prevention methods in this literature review.

Laser and Bimatoprost Combination Therapy Improve Facial Vitiligo

Findings suggest that this novel treatment approach can enhance the quality of life for vitiligo patients without increasing the risk of adverse events.

Ustekinumab Biosimilar Yestintek Launches in the US, Expanding Treatment Access for Chronic Autoimmune Diseases

Ustekinumab-kfce is available for the treatment of chronic autoimmune conditions like Crohn’s disease, ulcerative colitis, and plaque psoriasis.

SLIDESHOW: Exploring Merz Aesthetics' Global Confidence Study Data

Merz Aesthetics' global study highlights how aesthetic treatments boost self-confidence, well-being, and empower individuals, transforming self-care practices.

How the LIMITLESS Initiative Supports Female Leaders in Dermatology

Mindy Haws, MD, spoke to Dermatology Times about the new videos, podcasts, and other resources LIMITLESS offers for women at all stages of their careers.

Related Videos
infectious disease
© 2025 MJH Life Sciences

All rights reserved.